A Within‐Group Design of Nontreatment Seeking 5‐HTTLPR Genotyped Alcohol‐Dependent Subjects Receiving Ondansetron and Sertraline
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Background: Serotonergic mechanisms are associated with the development of alcohol dependence (AD), however, studies evaluating serotonergic medications have produced conflicting results. One hypothesis suggests that differential response may be due to a functional polymorphism of the 5‐HTTLPR promoter region of the serotonin re‐uptake transporter (5‐HTT). The L/L genotype is postulated to be associated with early onset alcoholism and the S/S or S/L genotypes associated with late onset alcoholism. The aim of this study was to match and mismatch L/L, S/S, or S/L genotypes with administration of ondansetron and sertraline. Methods: Fifteen nontreatment seeking alcohol‐dependent individuals were randomized to 1 of 2 counterbalanced arms to receive either 200 mg/d of sertraline or ondansetron 0.5 mg/d for 3 weeks followed by an alcohol self‐administration experiment (ASAE), then received placebo for 3 weeks followed by a second ASAE. Participants then received the alternate drug for 2 weeks followed by a third ASAE. Results: At the first ASAE compared to sertraline, ondansetron significantly improved drinking outcomes for the L/L genotype for the ASAE volume consumed (100% reduction based on between‐subjects comparison, t = 2.35), and for drinks per drinking day during the 7 days prior to the ASAE (79% reduction and t = 4.34). Compared with ondansetron for S/S or S/L genotypes, outcomes at ASAE 1 for sertraline and S/S or S/L genotypes are opposite than hypothesized. Overall, subjects reduced drinking across their participation in the trial, as there appears to be an order effect. Conclusion: This study suggests that ondansetron may reduce alcohol consumption in alcohol‐dependent individuals who have the L/L genotype as measured naturalistically and during the ASAE. By contrast there was no support that sertraline reduces alcohol use in individuals who have S/S or S/L genotypes. Evidence in the literature suggests that AD in some individuals may be influenced by a gene by socio‐environmental interaction making pharmacological treatment with serotonergic drugs complex. Research must consider that typologies may predict successful treatment of AD in future trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Allelic Variation of Human Serotonin Transporter Gene Expression
Heils, A., Teufel, A., Petri, S., Stöber, G., Riederer, P., Bengel, D., & Lesch, K. P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66062621.x · Cited by 2,221
SULLIVAN, J. T., SYKORA, K., SCHNEIDERMAN, J., NARANJO, C. A., & SELLERS, E. M. (1989) · British Journal of Addiction · doi:10.1111/j.1360-0443.1989.tb00737.x · Cited by 1,988 · cited 1×
“…participants who had significant alcohol withdrawal symptoms, Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar) revised score >10 (Sullivan et al., 1989); lifetime depression or a history of suicide; history of seizures (e.g. epilepsy) or migraine headaches; or current use of…”
BackgroundBohn, M. J., Babor, T. F., & Kranzler, H. R. (1995) · Journal of Studies on Alcohol · doi:10.15288/jsa.1995.56.423 · Cited by 1,356 · cited 1×
“Alcohol dependence as defined by an Alcohol Use Disorders Identification Test (AUDIT) (Bohn et al., 1995) score ‡12 and men must consume ‡35 and women ‡28 standardized alcoholic beverages a week.”
MethodThe genetics of addictions: uncovering the genes
Goldman, D., Oroszi, G., & Ducci, F. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1635 · Cited by 1,099 · cited 2×
“Studies in humans also demonstrate that 5-HT is an important modulator of the stress response (Goldman et al., 2005) and depression (Caspi et al.”
BackgroundTraining and quality assurance with the structured clinical interview for DSM-iV (SCID-I/P)
Ventura, J., Liberman, R. P., Green, M. F., Shaner, A., & Mintz, J. (1998) · Psychiatry Research · doi:10.1016/s0165-1781(98)00038-9 · Cited by 591 · cited 3×
“The study participants were diagnosed as alcohol-dependent as assessed by the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders–Text Revision (DSM IV-TR; American Psychiatric Association, 2000), were drinking ‡35 standard drinks ⁄week for men or ‡28 standard drinks ⁄week for w…”
MethodInfluentialMyrick, H., Anton, R. F., Li, X., Henderson, S., Randall, P. K., & Voronin, K. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.4.466 · Cited by 258 · cited 1×
“Furthermore, this is consistent with recent neuroimaging data showing the ability of ondansetron to reduce alcohol cue-induced activation of the ventral striatum (Myrick et al., 2008).”
ResultGenetic and Environmental Predictors of Early Alcohol Use
Kaufman, J., Yang, B.-Z., Douglas-Palumberi, H., Crouse-Artus, M., Lipschitz, D., Krystal, J. H., & Gelernter, J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.039 · Cited by 216
Anton, R. F., Drobes, D. J., Voronin, K., Durazo-Avizu, R., & Moak, D. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1720-7 · Cited by 135 · cited 1×
“An ASAE (see Anton et al., 2004; Drobes et al., 2003; O’Malley et al., 2002) was conducted at the end of each of the 3 medication phases.”
Cited by
Behavioral Addictions: An Overview
Karim, R., & Chaudhri, P. (2012) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2012.662859 · Cited by 239
Fontenelle, L. F., Oostermeijer, S., Harrison, B. J., Pantelis, C., & Yücel, M. (2011) · Drugs · doi:10.2165/11591790-000000000-00000 · Cited by 234
Medication treatment of different types of alcoholism
Johnson, B. A. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.08101500 · Cited by 151
Pharmacological approaches to reducing craving in patients with alcohol use disorders
Haass-Koffler, C. L., Leggio, L., & Kenna, G. A. (2014) · CNS Drugs · doi:10.1007/s40263-014-0149-3 · Cited by 83
“In addition, different genetic variations in the 5-HT system suggest that the diverse populations previously discussed, such as type A and type B alcoholics [113], may respond differentially to SSRI treatment [165–167] or may even benefit from treatment using specific 5-HT3-receptor antagonists [155, 168–170].”
Self-citationCorrêa Filho, J. M., & Baltieri, D. A. (2013) · Addictive Behaviors · doi:10.1016/j.addbeh.2012.12.018 · Cited by 26
Metadata
- Authors
- Kenna, G. A., Zywiak, W. H., McGeary, J. E., Leggio, L., McGeary, C., Wang, S., Grenga, A., & Swift, R. M.
- Venue
- Alcoholism: Clinical and Experimental Research
- Publisher
- Wiley
- Published
- 2009-01-22
- Volume
- 33
- Issue
- 2
- Pages
- 315-323
- ISSN
- 0145-6008 (ISSN-L)
- 1530-0277
- OpenAlex
- W2006133694
- Cited by
- 47
- References
- 8
- FWCI
- 1.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Within‐Group Design of Nontreatment Seeking 5‐HTTLPR Genotyped Alcohol‐Dependent Subjects Receiving Ondansetron and Sertraline. https://app.cochat.ai/papers/10.1111/j.1530-0277.2008.00835.x
- The paper
- Kenna, G. A., Zywiak, W. H., McGeary, J. E., Leggio, L., McGeary, C., Wang, S., Grenga, A., & Swift, R. M. (2009). A Within‐Group Design of Nontreatment Seeking 5‐HTTLPR Genotyped Alcohol‐Dependent Subjects Receiving Ondansetron and Sertraline. Alcoholism: Clinical and Experimental Research. https://doi.org/10.1111/j.1530-0277.2008.00835.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.